Allergy Asthma and Clinical Immunology · 2010 · 12 citations · 19 references
Life SciencesPharmacologyPharmacotherapyAllergyHypersensitivityPharmacovigilanceDrug AllergyPatch TestingSkin Prick TestingAsthma DiagnosisDermatologic Adverse EventsDrug Skin TestingImmediate Hypersensitivity TestingIntradermal Skin TestingSerious Adverse Events
RATIONALE: The use of beta-blockers is a relative contraindication in allergen skin testing yet there is a paucity of literature on adverse events in this circumstance. We examined a population of skin tested patients on beta-blockers to look for any adverse effects. METHODS: Charts from 2004-2008 in a single allergy clinic were reviewed for any patients taking a beta-blocker when skin tested. Data was examined for skin test reactivity, type of skin test, concomitant asthma diagnosis, allergens tested, and adverse events. RESULTS: One hundred and ninety-one patients were taking beta-blockers when skin testing occurred. Seventy-two patients had positive skin tests. No tests resulted in an adverse event. CONCLUSIONS: This data demonstrates the relative safety of administrating of skin prick tests to patients on beta-blocker treatment. Larger prospective studies are needed to substantiate the findings of this study.
19
Fatalities from immunotherapy (IT) and skin testing (ST)
Richard F. Lockey, Linda Benedict, Paul C. Turkeltaub et al. · Journal of Allergy and Clinical Immunology · 1987 · 582 citations · Full text